OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 257,900
- Value
- $309.3M
- % of portfolio
- 5.9%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 257,900 | $309.3M | 5.9% | +21,100+8.9% | Added | Holders |
| Q1 2026 | 236,800 | $217.8M | 4.9% | −64,400−21.4% | Reduced | Holders |
| Q4 2025 | 301,200 | $323.7M | 6.6% | 00.0% | Unchanged | Holders |
| Q3 2025 | 301,200 | $229.8M | 5.5% | −36,400−10.8% | Reduced | Holders |
| Q2 2025 | 337,600 | $263.2M | 6.6% | 00.0% | Unchanged | Holders |
| Q1 2025 | 337,600 | $278.8M | 6.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 337,600 | $260.6M | 5.4% | 00.0% | Unchanged | Holders |
| Q3 2024 | 337,600 | $299.1M | 5.5% | 00.0% | Unchanged | Holders |
| Q2 2024 | 337,600 | $305.7M | 6.5% | −23,200−6.4% | Reduced | Holders |
| Q1 2024 | 360,800 | $280.7M | 5.5% | −4,600−1.3% | Reduced | Holders |
| Q4 2023 | 365,400 | $213.0M | 4.3% | +179,400+96.5% | Added | Holders |
| Q3 2023 | 186,000 | $99.9M | 2.3% | 00.0% | Unchanged | Holders |
| Q2 2023 | 186,000 | $87.2M | 1.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 186,000 | $63.9M | 1.3% | +186,000 | New | Holders |